Tissue samples, tissue arrays, cells, microorganisms, probes and services for your research.
Payment methods we support:
✭ Invoice / Purchase Order
✭ Credit card
Nonalcoholic fatty liver disease (NAFLD) is characterized by evidence of hepatic steatosis and associates with obesity, diabetes, insulin resistance etc. The spectrum of nonalcoholic fatty liver disease ranges from simple steatosis to nonalcoholic steatohepatitis (NASH). Nonalcoholic steatohepatitis is characterized by inflammation and may progress to fibrosis, resulting in cirrhosis and hepatocellular carcinoma. In recent years, the incidence of NAFLD has increased significantly, which caused a severe economic burden worldwide.
Creative Bioarray has many years of experience in the field of NAFLD and provides pharmacodynamic services for customers to help them assess the efficacy of compounds and study the associated pathological mechanisms through NAFLD model.
Nonalcoholic fatty liver disease models include but not limited to:
With extensive experience in the field of NAFLD, we are confident to help you overcome any upcoming challenges. Our experts are fully capable of customizing our protocols and assays to meet your specific needs. With our help, we wish to facilitate your research with high efficiency.
Figure. 1. Effect of electrolyzed-alkaline water on body weight and composition. A: Body weight (n = 12, mean ± SD) c shows significant diference between high-fat and regular diets; B and C: Ventral view of dissected mice after 12 wk of the experiment. Black arrow: Retroperitoneal fat pads; white arrow epididymal fat pad. Insert: Fresh dissected liver. RW: Regular water; EAW: Electrolysed alkaline water; RD: Regular diet; HFD: High fat diet.
Figure. 2. Diosgenin ameliorates the hepatic lipid accumulation in high-fat diet-fed rats. (A) Hematoxylin and eosin (H&E) and Oil red O staining of the rat liver.
Quotation and ordering
If you have any special needs or questions regarding our services, please feel free to contact us at 631-626-9181 or firstname.lastname@example.org. We look forward to cooperating with you in the future.
Metabolic Disease Models: